Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials ; day:20 ; month:12 ; year:2023 ; pages:1-14
Neurological sciences ; (20.12.2023), 1-14
- Creator
-
Schilke, Edoardo Dalmato
Remoli, Giulia
Funelli, Eugenio
Galimberti, Michela
Fusco, Maria Letizia
Cereda, Diletta
Balducci, Claudia
Frigo, Maura
Cavaletti, Guido
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-023-07228-3
- URN
-
urn:nbn:de:101:1-2024030609151476289154
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schilke, Edoardo Dalmato
- Remoli, Giulia
- Funelli, Eugenio
- Galimberti, Michela
- Fusco, Maria Letizia
- Cereda, Diletta
- Balducci, Claudia
- Frigo, Maura
- Cavaletti, Guido
- SpringerLink (Online service)
Other Objects (12)
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Overview of Ongoing Clinical Trials on Radioembolization
Effect sizes in ongoing randomized controlled critical care trials
Molecular biomarkers in multiple sclerosis
Inadequate description of educational interventions in ongoing randomized controlled trials
Recent pharmacological advances on genistein in clinical trials
Changes to aspects of ongoing randomised controlled trials with fixed designs
A systematic review of ongoing clinical trials in optic pathway gliomas
Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Overview of Ongoing Clinical Trials on Radioembolization
Effect sizes in ongoing randomized controlled critical care trials
Molecular biomarkers in multiple sclerosis
Inadequate description of educational interventions in ongoing randomized controlled trials
Recent pharmacological advances on genistein in clinical trials
Changes to aspects of ongoing randomised controlled trials with fixed designs
A systematic review of ongoing clinical trials in optic pathway gliomas
Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Overview of Ongoing Clinical Trials on Radioembolization
Effect sizes in ongoing randomized controlled critical care trials
Molecular biomarkers in multiple sclerosis
Inadequate description of educational interventions in ongoing randomized controlled trials
Recent pharmacological advances on genistein in clinical trials
Changes to aspects of ongoing randomised controlled trials with fixed designs
A systematic review of ongoing clinical trials in optic pathway gliomas
Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials